admin

• Nanoligent Receives Innovation Recognition from Cerdanyola Empresarial

We are thrilled to announce that Nanoligent has been selected by the Associació d’Empreses de Cerdanyola del Vallès-Cerdanyola Empresarial to receive a coveted Innovation Recognition at the upcoming 10th Cerdanyola Business Night. The award ceremony, organized by Cerdanyola Empresarial, is set to take place on November 23rd at 8 pm at the Hotel Campus of …

• Nanoligent Receives Innovation Recognition from Cerdanyola Empresarial Read More »

• Nanoligent Joins Arquímedes Accelerator for Intensive Growth Program

Nanoligent is proud to announce its active participation in the Arquídemes Accelerator, a groundbreaking initiative in collaboration with Santander Bank (Universidades section). This first edition of the program is dedicated to fostering the growth of emerging companies, mainly spin-offs from the University. Over the two months, Nanoligent, along with 13 other cutting-edge companies, will benefit …

• Nanoligent Joins Arquímedes Accelerator for Intensive Growth Program Read More »

• Nanoligent raised €2.8 M and completed Seed round financing with support of i&i Biotech Fund I

PRESS RELEASE Barcelona, Spain September 27th 2022 – Nanoligent SL, a Spanish biotech company specialized in the development of cancer treatments based on unique protein conjugates, today announces the completion of a Seed financing round of total € 2.8 M. The final closing of the Seed round consists of € 1 M investment by i&i …

• Nanoligent raised €2.8 M and completed Seed round financing with support of i&i Biotech Fund I Read More »

• 6th MEET2WIN European Oncology Partnering Convention

Nanoligent has been selected for pitching next May 5th in the Oncology Upward Investment session of the 6th edition of the MEET2WIN European Oncology Partnering Convention. MEET2WIN is an European Partnering Convention fully dedicated to open innovation in oncology. For 2 days, the congress will host conferences, project pitches, one-to-one business meetings and an exhibition …

• 6th MEET2WIN European Oncology Partnering Convention Read More »

• 28th Healthcare Investment Forum, 24th March 2021

Nanoligent has been selected to showcase at the 28th Healthcare Investment Forum the next 24th of March. The Healthcare Barcelona Investment Forum is a meeting point for entrepreneurs and investors in the healthcare sector. All kinds of companies can be presented with projects related to Biotechnology, Medical Devices, Health Services and Information Technologies related to …

• 28th Healthcare Investment Forum, 24th March 2021 Read More »

biofit nanoligent marseille france start-up slam

• BioFIT 2019

Nanoligent was present in the 8th edition of the BioFIT partnering event that took place this past 10-11th of December in the French city of Marseille. We showcased our project in a 5-minute pitch during the Start-up Slam and established contact with potential partners and investors. As its organizers state, BioFIT has become the meeting …

• BioFIT 2019 Read More »

pegs europe nanoligent 2019

• PEGS Europe 2019

This recent 18-22th of November Nanoligent was present in the 11th Annual PEGS Europe summit, the largest European event covering all aspects of protein and antibody engineering. This year the summit broke its previous attendance records, with more than 1,300 participants and 250 scientific posters. Nanoligent presented the latest news regarding its technology and members …

• PEGS Europe 2019 Read More »

nanoligent farmaindustria farma-biotech invited companies start-up seven projects

• XVIII Farma-Biotech Cooperation Meeting

Last October 29th the employers’ organization of the pharmaceutical industry in Spain, Farmaindustria, organized its latest Farma-Biotech meeting to boost pre-clinical research. The event brings together representatives of national and international pharmaceutical companies with different Spanish biotechnology companies and research groups that have innovative clinical projects. Nanoligent and six other projects were hosted because according …

• XVIII Farma-Biotech Cooperation Meeting Read More »